Pharmaceutical giant strives to strengthen R&DSouth Korea’s top-tier pharmaceutical company CHA Biotech announced on Dec. 14 that it had named experienced expert Lee Hyun-jung as its new president.Under the stewardship of CEO Oh Sang-hoon, Lee will take charge of the research and development divisio
Pharmaceutical giant continues to chalk up growthSouth Korea’s top-tier pharmaceutical company CHA Biotech announced on Nov. 11 that it had racked up record sales during the third quarter of this year.The firm’s turnover amounted to 215.7 billion won ($175 million) during the July-September period t
Pharmaceutical giant’s half-year revenue nears W400 billionSouth Korea’s first-tier pharmaceutical company CHA Biotech announced on Aug. 12 that it had chalked up record sales during the first half of this year.The firm’s turnover amounted to 3,997 billion won ($325 million) during the January-June
CHA Biotech’s US affiliate strives to chalk up fast growthMatica Biotechnology strives to achieve 1 trillion won ($790 million) in sales by the end of this decade, according to its chief executive officer Song Yun-jeong on July 21.Toward that end, the U.S. affiliate of Korean medical giant CHA Biote